Literature DB >> 3881591

Uropathogenic properties of Proteus mirabilis and Proteus vulgaris.

P G Peerbooms, A M Verweij, D M MacLaren.   

Abstract

A group of faecal isolates of Proteus vulgaris and P. mirabilis was studied for the presence of possible virulence factors such as growth rates in urine and broth, haemolysin production, hydrophobicity, sensitivity to the bactericidal activity of human serum and cell invasiveness. Differences were found in haemolysin production, cell invasiveness and experimental virulence in a mouse model. These differences might explain why P. mirabilis is much more common in human urinary-tract infections than P. vulgaris.

Entities:  

Mesh:

Year:  1985        PMID: 3881591     DOI: 10.1099/00222615-19-1-55

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Genotyping of urinary and fecal Proteus mirabilis isolates from individuals with long-term urinary catheters.

Authors:  S Mathur; N A Sabbuba; M T E Suller; D J Stickler; R C L Feneley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

Review 2.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

3.  Urinary pathogenicity of Proteus mirabilis strains isolated from faeces or urine.

Authors:  P G Peerbooms; A M Verweij; P L Oe; D M MacLaren
Journal:  Antonie Van Leeuwenhoek       Date:  1986       Impact factor: 2.271

4.  Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.

Authors:  W Kaca; A Rózalski
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

5.  Internalization of Proteus mirabilis by human renal epithelial cells.

Authors:  G R Chippendale; J W Warren; A L Trifillis; H L Mobley
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

Review 6.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Cytotoxic activity of the Proteus hemolysin HpmA.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

8.  The HpmA hemolysin is more common than HlyA among Proteus isolates.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Hemolytic activity and invasiveness in strains of Proteus penneri.

Authors:  A Rozalski; K Kotełko
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

10.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.